Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million http://biz.yahoo.com/prnews/071220/aqth106.html?.v=28 This came out of nowhere. Even if CEGE and its investigators occasionally spin data analysis, their spin-off of Abgenix, Ceregene and now this and their continuing collaboration with John Hopkins in oncology are pretty impressive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.